DOE Patents title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Methods for diagnosing bacterial infections

Abstract

The present invention is directed to methods of determining the presence or absence of a bacterial infection in a patient using isotopically-labeled tyrosine and/or isotopically-labeled p-hydroxyphenylacetic acid.

Inventors:
;
Issue Date:
Research Org.:
Los Alamos National Laboratory (LANL), Los Alamos, NM (United States)
Sponsoring Org.:
USDOE
OSTI Identifier:
1459532
Patent Number(s):
10000787
Application Number:
14/434,509
Assignee:
STC.UNM (Albuquerque, NM); LOS ALAMOS NATIONAL SECURITY, LLC. (Los Alamos, NM)
Patent Classifications (CPCs):
A - HUMAN NECESSITIES A61 - MEDICAL OR VETERINARY SCIENCE A61B - DIAGNOSIS
C - CHEMISTRY C12 - BIOCHEMISTRY C12Q - MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS
DOE Contract Number:  
AC52-06NA25396
Resource Type:
Patent
Resource Relation:
Patent File Date: 2013 Oct 08
Country of Publication:
United States
Language:
English

Citation Formats

Timmins, Graham, and Silks, Louis Pete. Methods for diagnosing bacterial infections. United States: N. p., 2018. Web.
Timmins, Graham, & Silks, Louis Pete. Methods for diagnosing bacterial infections. United States.
Timmins, Graham, and Silks, Louis Pete. Tue . "Methods for diagnosing bacterial infections". United States. https://www.osti.gov/servlets/purl/1459532.
@article{osti_1459532,
title = {Methods for diagnosing bacterial infections},
author = {Timmins, Graham and Silks, Louis Pete},
abstractNote = {The present invention is directed to methods of determining the presence or absence of a bacterial infection in a patient using isotopically-labeled tyrosine and/or isotopically-labeled p-hydroxyphenylacetic acid.},
doi = {},
journal = {},
number = ,
volume = ,
place = {United States},
year = {2018},
month = {6}
}

Works referenced in this record:

Increase in Adult Clostridium difficile –related Hospitalizations and Case-Fatality Rate, United States, 2000–2005
journal, June 2008


13[C]-Urea Breath Test as a Novel Point-of-Care Biomarker for Tuberculosis Treatment and Diagnosis
journal, August 2010


Diagnostic agent for diabetes
patent, January 2003


The economic burden of Clostridium difficile
journal, March 2012


Methods for detecting bacterial infections
patent, December 2016


Prospective study of Clostridium difficile colonization and para-cresol detection in the stools of babies on a special care unit
journal, August 1984


Mass Markers and Methods
patent-application, June 2011


Toxicity of Free p-Cresol: A Prospective and Cross-Sectional Analysis
journal, March 2003


Assessing the role of p-cresol tolerance in Clostridium difficile
journal, June 2008


The analysis of para-cresol production and tolerance in Clostridium difficile 027 and 012 strains
journal, January 2011